Vanda Pharmaceuticals Inc. (VNDA) ownership: Top institutional holder: BlackRock, Inc. ($50.28M). Insider activity: Net Seller (0 buys, 13 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 7275988.00 | $50.28M | 2026-03-31 |
| BlackRock Fund Advisors | 2270297.00 | $36.21M | 2016-12-31 |
| VANGUARD GROUP INC | 3731851.00 | $32.91M | 2025-12-31 |
| RENAISSANCE TECHNOLOGIES LLC | 3759559.00 | $25.98M | 2026-03-31 |
| STATE STREET CORP | 3015562.00 | $20.84M | 2026-03-31 |
| AIGH Capital Management LLC | 2750000.00 | $19.00M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2481491.00 | $17.15M | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 1881001.00 | $13.00M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-18 | |
| Sell | null | 2026-04-22 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-03-02 | |
| Sell | null | 2026-02-23 |
Back to VNDA overview · VNDA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.